Baxter International Inc. (BAX)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 12 | 12 | 10 | 10 | 11 | 11 | 11 | 12 |
| Operating profit | $bn | -0 | -0 | ||||||
| Net profit | $bn | 1 | 1 | -2 | 3 | -1 | -1 | -1 | 1 |
| EPS reported | $ | -1.75 | -2.04 | ||||||
| Operating cashflow per share | $ | 1.65 | 2.55 | ||||||
| Capex per share | $ | 1.02 | 1.24 | ||||||
| FCF per share | $ | 0.63 | 1.31 | ||||||
| Free cash flow | $bn | 0 | 1 | ||||||
| Net debt | $bn | 8 | 7 | ||||||
| Book value equity | $bn | 6 | 6 | ||||||
| Book value per share | $ | 11.95 | 11.98 | ||||||
| Number of shares | m | 513 | 518 | ||||||
| DPS (TTM paid) | $ | 0.52 | 0.04 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.60 | 1.58 | ||||||
| P/S LTM | x | 0.87 | 0.85 | ||||||
| P/FCF LTM | x | 30.35 | 14.46 | ||||||
| EV/EBITDA LTM | x | 23.29 | 23.79 | ||||||
| EV/Sales LTM | x | 1.59 | 1.82 | ||||||
| Earnings Yield LTM | % | -9.76% | -7.96% | ||||||
| FCF Yield | % | +3.29% | +6.92% | ||||||
| Quality | |||||||||
| ROE | % | -15.61% | -16.60% | ||||||
| ROIC | % | -1.79% | -1.61% | ||||||
| Operating margin | % | -2.74% | -2.39% | ||||||
| Gross margin | % | +30.05% | +30.08% | ||||||
| FCF/Sales | % | +2.87% | +5.91% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +5.72% | +7.84% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -42.22% | +21.29% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +3.55% | +0.15% | ||||||
| Dividend Growth | % | -50.00% | -96.15% | ||||||
| Payout Ratio | % | -38.76% | -17.99% | ||||||
| FCF/Debt | x | 0.03 | 0.07 | ||||||
| Net Debt/EBITDA | x | 10.49 | 10.02 | ||||||
| EBIT/Net interest | x | -1.06 | -0.94 | ||||||
| Net debt/market cap | % | +99.55% | +70.83% | ||||||
| Net debt/Equity | x | 1.27 | 1.18 | ||||||
| Gross debt/equity | x | 1.63 | 1.56 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free